Alzamend Neuro, Inc. - Common Stock (NQ:ALZN)

1.160 +0.020 (+1.75%)

Delayed Quote Updated: 10:16 AM EDT, Oct 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Alzamend Neuro, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

May 08, 2024

Via Benzinga

Alzamend Neuro Halts Equity Offering Program, Prioritizing Shareholder Value Amid Strategic Shift, Shares Slide ↗

May 07, 2024

Alzemend Neuro made waves Tuesday when the company announced its decision to terminate its "at-the-market" equity offering program. Shares were down nearly 12% at last check.

Via Benzinga

Alzamend Neuro Announces Termination of At-the-Market Equity Offering Program

May 07, 2024

From Alzamend Neuro, Inc.

Via Business Wire

ALZN Stock Earnings: Alzamend Neuro Reported Results for Q2 2024 ↗

December 18, 2023

Alzamend Neuro just reported results for the second quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Friday's After-Market Session ↗

May 03, 2024

Via Benzinga

Alzamend Neuro And 2 Other Stocks Under $5 Insiders Are Buying ↗

April 24, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

April 16, 2024

Via Benzinga

Aldeyra Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying ↗

April 04, 2024

The Dow Jones index closed lower by around 0.1% on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Topics Stocks

Silo Pharma And 3 Other Stocks Under $5 Insiders Are Buying ↗

April 02, 2024

The Dow Jones index closed lower by over 200 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

March 27, 2024

Via Benzinga

ALZN Stock Earnings: Alzamend Neuro Misses EPS for Q3 2024 ↗

March 26, 2024

ALZN stock results show that Alzamend Neuro missed analyst estimates for earnings per share the third quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

February 13, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

February 12, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

February 01, 2024

Via Benzinga

Alzamend Neuro And 3 Other Stocks Under $3 Insiders Are Buying ↗

January 10, 2024

$1.5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

December 19, 2023

Via Benzinga

ALZN Stock Earnings: Alzamend Neuro Beats EPS for Q1 2024 ↗

December 18, 2023

ALZN stock results show that Alzamend Neuro beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

EXCLUSIVE: Alzamend Neuro Plans To Kickstart Stress Disorder Study With Next-Gen Lithium Product Next Year ↗

December 11, 2023

Alzamend Neuro Inc (NASDAQ: ALZN) received a "Study May Proceed" letter from the FDA for the initiation of study AL001-PTSD01, a Phase 2A study of AL001 for

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 30, 2023

Via Benzinga

Alzamend Neuro Receives FDA “Study May Proceed” Notification for a Phase IIA Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, in Post-Traumatic Stress Disorder Patients

December 11, 2023

From Alzamend Neuro, Inc.

Via Business Wire

Why American Eagle Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

November 21, 2023

Shares of American Eagle Outfitters, Inc. (NYSE: AEO) declined during Tuesday’s session after the company reported third-quarter financial results. Net revenue rose 5% Y/Y to $1.30 billion, beating the...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 21, 2023

Via Benzinga

Why Symbotic Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket ↗

November 21, 2023

Shares of Symbotic Inc. (NASDAQ: SYM) surged in pre-market trading after the company reported better-than-expected fourth-quarter sales results.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

November 21, 2023

It's time to start Tuesday trading with a breakdown of the biggest pre-market stock movers worth keeping an eye on this morning!

Via InvestorPlace

12 Health Care Stocks Moving In Monday's After-Market Session ↗

November 20, 2023

Via Benzinga

Why ReNew Energy Global Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

November 20, 2023

Shares of ReNew Energy Global Plc (NASDAQ: RNW) gained during Monday’s session following strong quarterly sales. ReNew Energy Global posted quarterly sales of $345.00 million, topping market estimates...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 20, 2023

Via Benzinga

Alzamend Neuro Receives FDA “Study May Proceed” Notification for a Phase IIA Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, in Major Depressive Disorder Patients

November 20, 2023

From Alzamend Neuro, Inc.

Via Business Wire

EXCLUSIVE: Alzamend Neuro Receives FDA Go-Ahead Letter For Mid-Stage Major Depressive Disorder Study ↗

November 20, 2023

Alzamend Neuro Inc (NASDAQ: ALZN) has received a "Study May Proceed" letter from the FDA for the initiation of study AL001-MDD01, a Phase 2A clinical study of AL001 for

Via Benzinga

Alzamend Neuro Regains Compliance with Nasdaq’s Minimum Bid Price Requirement

November 16, 2023

From Alzamend Neuro, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.